These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2869743)

  • 1. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR; Rubinow DR; Roy A; Pickar D
    Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid somatostatin and psychiatric illness.
    Rubinow DR
    Biol Psychiatry; 1986 Apr; 21(4):341-65. PubMed ID: 2869790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
    Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of CSF somatostatin concentrations in mania.
    Sharma RP; Bissette G; Janicak PG; Davis JM; Nemeroff CB
    Am J Psychiatry; 1995 Dec; 152(12):1807-9. PubMed ID: 8526251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of somatostatin in human CSF mark depressive episodes.
    Agren H; Lundqvist G
    Psychoneuroendocrinology; 1984; 9(3):233-48. PubMed ID: 6149588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of diagnosis and age on the DST: a metaanalytic approach.
    Sharma RP; Pandey GN; Janicak PG; Peterson J; Comaty JE; Davis JM
    Biol Psychiatry; 1988 Sep; 24(5):555-68. PubMed ID: 3167144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in depression.
    Dam H; Mellerup ET; Rafaelsen OJ
    J Affect Disord; 1985; 8(1):95-103. PubMed ID: 3156917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
    Roy A; Pickar D; Paul S; Doran A; Chrousos GP; Gold PW
    Am J Psychiatry; 1987 May; 144(5):641-5. PubMed ID: 3495188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the adrenal cortex in patients with major depression.
    Kalin NH; Dawson G; Tariot P; Shelton S; Barksdale C; Weiler S; Thienemann M
    Psychiatry Res; 1987 Oct; 22(2):117-25. PubMed ID: 2825229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females.
    Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Scharpe S; Blockx P
    Biol Psychiatry; 1990 Mar; 27(6):601-8. PubMed ID: 2322619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test: importance of dexamethasone concentrations.
    Maguire KP; Schweitzer I; Biddle N; Bridge S; Tiller JW
    Biol Psychiatry; 1987 Aug; 22(8):957-67. PubMed ID: 3607137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.